Citrate-Presenting Polymer Network for Bone Growth
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing biomaterials for bone applications often fail to match the native composition of bone, provide adequate mechanical support, minimize inflammatory responses, and promote rapid bone regeneration and integration with surrounding tissue effectively.
Innovation Solution
A citrate-presenting composition comprising a polymer or oligomer with a citrate moiety, blended with another polymer or oligomer and cross-linked, along with particulate materials like hydroxyapatite, to form a polymer network that promotes bone growth and integration, while also inhibiting cancer cell growth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If existing biomaterials are used for bone applications, then they provide structural support, but they fail to match the native composition of bone and provide adequate mechanical support
Solution Approach 1:
The invention uses composite materials consisting of citrate-presenting polymers blended with particulate materials (hydroxyapatite, tricalcium phosphate, bioglass, or ceramic) to create a biomimetic composition that matches native bone structure. The composite combines the mechanical properties of inorganic particles with the biocompatibility of citrate-containing polymers, achieving both strength and compositional fidelity to native bone.
Solution Approach 2:
The invention modifies the chemical composition parameters of biomaterials by incorporating citrate moieties into the polymer structure and controlling the ratio of inorganic to organic components. This parameter adjustment allows the material to more closely resemble native bone composition while maintaining adequate mechanical strength for load-bearing applications.
2Object-affected harmful factors
If existing biomaterials are used for bone applications, then they provide structural support, but they fail to minimize inflammatory responses
Solution Approach 1:
The invention converts the potential harm of inflammatory responses into a beneficial outcome by using citrate-presenting materials that actively reduce inflammation. The citrate moieties in the polymer structure modulate the immune response, transforming what would be a harmful inflammatory reaction into a controlled, beneficial healing process while maintaining structural integrity.
Solution Approach 2:
The invention changes the chemical surface properties and composition parameters of the biomaterial to reduce immunogenicity. By incorporating citrate groups and optimizing the inorganic-organic ratio, the material presents a surface that is less likely to trigger inflammatory responses while retaining sufficient mechanical strength for bone support.
3Productivity
If existing biomaterials are used for bone applications, then they provide structural support, but they fail to quickly promote bone regeneration and integrate with surrounding tissue
Solution Approach 1:
The invention prepares the biomaterial surface in advance by incorporating citrate-presenting groups that are pre-configured to interact with bone cells and promote osteogenesis. The particulate materials are pre-coated or blended with citrate-containing polymers to create a surface that immediately upon implantation begins promoting bone cell attachment, proliferation, and differentiation, accelerating regeneration while maintaining structural support.
Solution Approach 2:
The composite structure combines citrate-presenting polymers with osteoconductive particulate materials to create a multifunctional scaffold. The citrate moieties promote cellular interactions and bone regeneration, while the inorganic particles provide mechanical strength and osteoconductivity, achieving both rapid bone growth and structural support simultaneously.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The citrate-presenting composition enhances mechanical properties, reduces inflammatory responses, improves biodegradability, and promotes bone growth by up-regulating osterix and alkaline phosphatase gene expression, leading to superior integration with bone tissue and inhibition of cancer cell proliferation.
Implementation Method 1
promotes bone growth by up-regulating osterix and alkaline phosphatase gene expression
Implementation Method 2
a first polymer or oligomer is blended with a second polymer or oligomer, wherein the first polymer or oligomer and the second polymer or oligomer are cross linked with one another to form a polymer network
Implementation Method 3
the composition further comprises a particulate material dispersed in the polymer network
Data Source
AI summary
In one aspect, methods of promoting bone growth are described herein. In some embodiments, a method of promoting bone growth described herein comprises promoting cell differentiation or phenotype progression in a population of bone cells by providing a citrate-presenting composition to the population of bone cells. In some embodiments, the citrate-presenting composition is provided to the bone cells at a first stage of cell development selected to obtain a first cell differentiation or phenotype progression. Additionally, in some cases, a second citrate-presenting composition is further provided to the bone cells at a second stage of cell development selected to obtain a second cell differentiation or phenotype progression.